MedTrace Logo

Expression Profiling of microRNA Following Administration of Dexmedetomidine

NCT03213743 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2017-07-11

No results posted yet for this study

Summary

The purpose of the study is to find out the differential expression profiling of microRNA before and after adiministration of dexmedetomidine in patients undergoing procedures, and then investigators will do some in vitro studies to validate the functions of the microRNA.

Conditions

  • Coronary Disease

Interventions

DRUG

Dexmedetomidine Injection

Investigators gave the patients loading dose of dexmedetomidine for 10 minutes and maintaining dose of dexmedetomidine for 20 minutes. Investigators took blood samples before and after the administration of dexmedetomidine.

Sponsors & Collaborators

  • First Affiliated Hospital of Kunming Medical University

    lead OTHER

Principal Investigators

  • Jinqiao Qian, Ph.D · First Affiliated Hospital of Kunming Medical University

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-19
Primary Completion
2017-06-21
Completion
2017-06-21

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03213743 on ClinicalTrials.gov